Fidelity Investments
BOLD icon

Fidelity Investments’s Boundless Bio BOLD Stock Holding History

Fidelity Investments’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.44M Sell
2,564,355
-16,700
-0.6% -$45K ﹤0.01% 2347
2026
Q2 		$6.45M Sell
2,581,055
-114,400
-4% -$176K ﹤0.01% 2329
2026
Q1 		$2.96M Buy
2,695,455
+11,433
+0.4% +$13.4K ﹤0.01% 2499
2025
Q4 		$3.22M Sell
2,684,022
-414,049
-13% -$516K ﹤0.01% 2431
2025
Q3 		$3.81M Sell
3,098,071
-27,032
-0.9% -$31.2K ﹤0.01% 2326
2025
Q2 		$3.16M Sell
3,125,103
-32,669
-1% -$43.4K ﹤0.01% 2327
2025
Q1 		$4.77M Sell
3,157,772
-187,234
-6% -$388K ﹤0.01% 2167
2024
Q4 		$9.7M Buy
3,345,006
+6,922
+0.2% +$20.2K ﹤0.01% 1949
2024
Q3 		$11.6M Sell
3,338,084
-96
-0% -$348 ﹤0.01% 1876
2024
Q2 		$12.9M Buy
3,338,180
+74,912
+2% +$716K ﹤0.01% 1796
2024
Q1 		$48.1M Buy
+3,263,268
New +$46.5M ﹤0.01% 1339

Other funds holding BOLD

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments's BOLD Position: Q3 2026 in Review

Fidelity Investments reduced its Boundless Bio (BOLD) stake by 0.65% in Q3 2026, selling an estimated $45K and leaving 2,564,355 shares worth $6.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

Fidelity Investments first reported a position in BOLD in Q1 2024 and has held it in 11 quarters since. The position peaked at $48.1M in Q1 2024. 9 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • Fidelity Investments held 2,564,355 shares of Boundless Bio worth $6.44M as of Q3 2026.
  • Fidelity Investments sold 16,700 Boundless Bio shares in Q3 2026, an estimated $45K.
  • Boundless Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2347 holding.
  • Fidelity Investments first reported a position in Boundless Bio in Q1 2024 and has held it in 11 quarters since.
  • Fidelity Investments's Boundless Bio position peaked at $48.1M in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.